NCT06175247

Brief Summary

The goal of this clinical trial is to learn about the low glycemic index diet in pregnant people with epilepsy. The main questions it aims to answer are:

  • Is the low glycemic index tolerable in pregnant people with epilepsy?
  • Does the low glycemic index alter seizure frequency in pregnant people with epilepsy?
  • Does the low glycemic index alter the gut bacteria \& associated metabolic pathways in pregnant people with epilepsy? Participants will start the low glycemic index diet during pregnancy and will provide stool and blood samples a maximum of 3 times during study duration. Researchers will compare pregnant people with epilepsy on the diet to pregnant people with epilepsy not on a structured diet plan to see if tolerability, seizure frequency, and gut bacteria composition \& metabolites differ.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

December 15, 2023

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 18, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

December 18, 2023

Status Verified

December 1, 2023

Enrollment Period

1.9 years

First QC Date

October 27, 2023

Last Update Submit

December 14, 2023

Conditions

Keywords

low glycemic index dietpregnancy

Outcome Measures

Primary Outcomes (1)

  • Tolerability of the low glycemic index diet in pregnant people with epilepsy

    Tolerability will be measured by the number of participants able to continue the diet in pregnancy with diet questionnaires + dietician follow up visits.

    During the diet intervention and immediately after the diet intervention

Secondary Outcomes (3)

  • Seizure Frequency

    Baseline pre-intervention, during the intervention, and through 3 months post-partum.

  • Gut Bacteria Composition

    During the intervention until 3 months postpartum

  • Metabolic pathway alterations

    During the intervention until 3 months postpartum

Study Arms (2)

Low Glycemic Index Diet Group

EXPERIMENTAL

A low glycemic index diet will be started with ongoing dietician support \& food questionnaires until pregnancy completion.

Other: Low Glycemic Index Diet

Standard Diet Group

NO INTERVENTION

A standard diet, as chosen by participants, will be followed with ongoing food questionnaires until pregnancy completion.

Interventions

A low glycemic diet will be initiated with dietician support and guidance.

Low Glycemic Index Diet Group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsEligibility is based on gestational potential.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of focal or generalized epilepsy as defined by the International League Against Epilepsy
  • Pregnant up to 20 weeks gestational age

You may not qualify if:

  • Functional neurologic disorder
  • Primary gastrointestinal disease
  • Antibiotic use in past 3 months
  • Diabetes
  • Seizure freedom

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Regan J Lemley, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Instructor of Neurology, Division of Epilepsy

Study Record Dates

First Submitted

October 27, 2023

First Posted

December 18, 2023

Study Start

December 15, 2023

Primary Completion

November 1, 2025

Study Completion

November 1, 2025

Last Updated

December 18, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations